PART I . Our Company We are a global leader in biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. MIDD is an approach that utilizes biological and statistical models derived from preclinical, clinical, and evidence data to inform decision-making in drug research and development, and commercialization. Biosimulation is a critical component of MIDD that uses computer-aided mathematical si...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001827090-26-000011 | EDGAR | 70K words |
| 2025-02-26 | 2024-12-31 | 0001827090-25-000014 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001827090-24-000006 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001558370-23-002605 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001558370-22-002608 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001558370-21-002979 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001827090-25-000048 | EDGAR | 26K words |
| 2025-08-06 | 2025-06-30 | 0001827090-25-000036 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0001827090-25-000028 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001827090-24-000037 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001827090-24-000029 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001827090-24-000013 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001827090-23-000021 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001827090-23-000010 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001558370-23-008541 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001558370-22-016642 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001558370-22-012907 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001558370-22-007443 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001104659-26-037798 | EDGAR | 1K words |
| 2026-02-26 | 0001827090-26-000008 | EDGAR | — |
| 2025-12-11 | 0001104659-25-120096 | EDGAR | — |
| 2025-11-06 | 0001827090-25-000046 | EDGAR | — |
| 2025-10-16 | 0001104659-25-100106 | EDGAR | — |
| 2025-08-06 | 0001827090-25-000034 | EDGAR | — |
| 2025-05-22 | 0001104659-25-052027 | EDGAR | — |
| 2025-05-05 | 0001827090-25-000026 | EDGAR | — |
| 2025-04-14 | 0001827090-25-000021 | EDGAR | — |
| 2025-03-05 | 0001827090-25-000018 | EDGAR | — |
88 total filings indexed. 60 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001827090 |
| Ticker | CERT |
| Exchange | Nasdaq |
| SIC | 7372: Services-Prepackaged Software |
| Incorporated | DE |
| Website | https://www.certara.com |
| Listed | 2020-12-11 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report